{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T05:11:27Z","timestamp":1792645887503,"version":"4.5.0"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.phrs.2022.106291","type":"journal-article","created":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T12:22:15Z","timestamp":1654690935000},"page":"106291","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"special_numbering":"C","title":["Saccharomyces boulardii, a yeast probiotic, inhibits gut motility through upregulating intestinal serotonin transporter and modulating gut microbiota"],"prefix":"10.1016","volume":"181","author":[{"given":"Yu","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiali","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingqian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runxiang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bangmao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.phrs.2022.106291_bib1","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41575-020-0286-8","article-title":"Global burden of irritable bowel syndrome: trends, predictions and risk factors","volume":"17","author":"Black","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"26","key":"10.1016\/j.phrs.2022.106291_bib2","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1056\/NEJMra1607547","article-title":"Irritable bowel syndrome","volume":"376","author":"Ford","year":"2017","journal-title":"NEW Engl. J. Med"},{"issue":"3","key":"10.1016\/j.phrs.2022.106291_bib3","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/s41395-018-0377-0","article-title":"Evidence for local and systemic immune activation in functional dyspepsia and the irritable bowel syndrome: a systematic review","volume":"114","author":"Burns","year":"2019","journal-title":"Am. J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.phrs.2022.106291_bib4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1053\/j.gastro.2019.05.042","article-title":"The role for food allergies in the pathogenesis of irritable bowel syndrome: understanding mechanisms of intestinal mucosal responses against food antigens","volume":"157","author":"Choung","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.phrs.2022.106291_bib5","doi-asserted-by":"crossref","first-page":"16014","DOI":"10.1038\/nrdp.2016.14","article-title":"Irritable bowel syndrome","volume":"2","author":"Enck","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"9","key":"10.1016\/j.phrs.2022.106291_bib6","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1001\/jama.2015.0954","article-title":"Irritable bowel syndrome: a clinical review","volume":"313","author":"Chey","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.phrs.2022.106291_bib7","article-title":"The effect of Saccharomyces boulardii primary prevention on risk of Hospital Onset Clostridioides difficile infection in hospitalized patients administered antibiotics frequently associated with Clostridioides difficile infection","author":"Wombwell","year":"2020","journal-title":"Clin. Infect. Dis."},{"issue":"9","key":"10.1016\/j.phrs.2022.106291_bib8","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1038\/ajg.2012.222","article-title":"Saccharomyces boulardii and antibiotic-associated diarrhea: effectiveness of prophylactic use","volume":"107","author":"Zocco","year":"2012","journal-title":"Am. J. Gastroenterol."},{"issue":"6","key":"10.1016\/j.phrs.2022.106291_bib9","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1080\/08923973.2018.1469143","article-title":"Review of Saccharomyces boulardii as a treatment option in IBD","volume":"40","author":"Sivananthan","year":"2018","journal-title":"Immunopharmacol. Immunotoxicol."},{"issue":"3","key":"10.1016\/j.phrs.2022.106291_bib10","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13985","article-title":"Saccharomyces boulardii CNCM I-745 modulates the microbiota-gut-brain axis in a humanized mouse model of irritable bowel syndrome","volume":"33","author":"Constante","year":"2021","journal-title":"Neurogastroenterol. Motil."},{"issue":"18","key":"10.1016\/j.phrs.2022.106291_bib11","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.3748\/wjg.v16.i18.2202","article-title":"Systematic review and meta-analysis of Saccharomyces boulardii in adult patients","volume":"16","author":"McFarland","year":"2010","journal-title":"World J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.phrs.2022.106291_bib12","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1590\/S0004-28032013000400012","article-title":"Treatment of diarrhea-predominant irritable bowel syndrome with mesalazine and\/or Saccharomyces boulardii","volume":"50","author":"Bafutto","year":"2013","journal-title":"Arq. Gastroenterol."},{"issue":"8","key":"10.1016\/j.phrs.2022.106291_bib13","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1097\/MCG.0b013e3182166c76","article-title":"Treatment of irritable bowel syndrome with Saccharomyces boulardii","volume":"45","author":"Guslandi","year":"2011","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.phrs.2022.106291_bib14","article-title":"Saccharomyces boulardii CNCM I-745 supplementation reduces gastrointestinal dysfunction in an animal model of IBS","volume":"12","author":"Brun","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.phrs.2022.106291_bib15","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1053\/j.gastro.2006.11.002","article-title":"The serotonin signaling system: from basic understanding to drug development for functional GI disorders","volume":"132","author":"Gershon","year":"2007","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.phrs.2022.106291_bib16","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/MED.0b013e32835bc703","article-title":"5-Hydroxytryptamine (serotonin) in the gastrointestinal tract","volume":"20","author":"Gershon","year":"2013","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"10.1016\/j.phrs.2022.106291_bib17","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.biochi.2018.06.008","article-title":"Serotonin in the gut: blessing or a curse","volume":"161","author":"Banskota","year":"2019","journal-title":"Biochimie"},{"key":"10.1016\/j.phrs.2022.106291_bib18","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3389\/fncel.2017.00222","article-title":"Serotonin transporter genotype modulates the gut microbiota composition in young rats, an effect augmented by early life stress","volume":"11","author":"El Aidy","year":"2017","journal-title":"Front Cell Neurosci."},{"issue":"7","key":"10.1016\/j.phrs.2022.106291_bib19","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1053\/j.gastro.2004.03.013","article-title":"Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome","volume":"126","author":"Coates","year":"2004","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.phrs.2022.106291_bib20","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3892\/mmr.2013.1784","article-title":"Increased serotonin transporter immunoreactivity intensity in the ileum of patients with irritable bowel disease","volume":"9","author":"Wendelbo","year":"2014","journal-title":"Mol. Med Rep."},{"issue":"1","key":"10.1016\/j.phrs.2022.106291_bib21","doi-asserted-by":"crossref","first-page":"10322","DOI":"10.1038\/s41598-017-10835-8","article-title":"Dysbiosis contributes to chronic constipation development via regulation of serotonin transporter in the intestine","volume":"7","author":"Cao","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.phrs.2022.106291_bib22","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1053\/j.gastro.2005.09.031","article-title":"Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome","volume":"130","author":"Atkinson","year":"2006","journal-title":"Gastroenterology"},{"issue":"16","key":"10.1016\/j.phrs.2022.106291_bib23","doi-asserted-by":"crossref","first-page":"6348","DOI":"10.1523\/JNEUROSCI.21-16-06348.2001","article-title":"Maintenance of serotonin in the intestinal mucosa and ganglia of mice that lack the high-affinity serotonin transporter: Abnormal intestinal motility and the expression of cation transporters","volume":"21","author":"Chen","year":"2001","journal-title":"J. Neurosci."},{"issue":"36","key":"10.1016\/j.phrs.2022.106291_bib24","doi-asserted-by":"crossref","first-page":"8137","DOI":"10.3748\/wjg.v22.i36.8137","article-title":"Regulation of the serotonin transporter in the pathogenesis of irritable bowel syndrome","volume":"22","author":"Jin","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.phrs.2022.106291_bib25","doi-asserted-by":"crossref","first-page":"24580","DOI":"10.1038\/srep24580","article-title":"EGFR inhibition blocks palmitic acid-induced inflammation in cardiomyocytes and prevents hyperlipidemia-induced cardiac injury in mice","volume":"6","author":"Li","year":"2016","journal-title":"Sci. Rep."},{"issue":"26","key":"10.1016\/j.phrs.2022.106291_bib26","doi-asserted-by":"crossref","first-page":"15871","DOI":"10.1073\/pnas.2036503100","article-title":"Antitumor efficacy of cytotoxic drugs and the monoclonal antibody 806 is enhanced by the EGF receptor inhibitor AG1478","volume":"100","author":"Johns","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2022.106291_bib27","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.13662","article-title":"Fecal imaging demonstrates that low-methoxyl pectin supplementation normalizes gastro-intestinal transit in mice given a liquid diet","volume":"6","author":"Kagawa","year":"2018","journal-title":"Physiol. Rep."},{"key":"10.1016\/j.phrs.2022.106291_bib28","doi-asserted-by":"crossref","first-page":"4381","DOI":"10.1038\/s41598-019-40978-9","article-title":"Alteration of GLP-1\/GPR43 expression and gastrointestinal motility in dysbiotic mice treated with vancomycin","volume":"9","author":"Xu","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.phrs.2022.106291_bib29","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s40168-018-0587-0","article-title":"Estrogen-mediated gut microbiome alterations influence sexual dimorphism in metabolic syndrome in mice","volume":"6","author":"Kaliannan","year":"2018","journal-title":"Microbiome"},{"issue":"1","key":"10.1016\/j.phrs.2022.106291_bib30","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s40168-021-01115-9","article-title":"Gut microbiota from green tea polyphenol-dosed mice improves intestinal epithelial homeostasis and ameliorates experimental colitis","volume":"9","author":"Wu","year":"2021","journal-title":"Microbiome"},{"issue":"5","key":"10.1016\/j.phrs.2022.106291_bib31","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1039\/D0FO02848G","article-title":"Puerarin from Pueraria lobata alleviates the symptoms of irritable bowel syndrome-diarrhea","volume":"12","author":"Wang","year":"2021","journal-title":"Food Funct."},{"key":"10.1016\/j.phrs.2022.106291_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2020.109674","article-title":"LncRNA XIST modulates 5-hydroxytrytophan-induced visceral hypersensitivity by epigenetic silencing of the SERT gene in mice with diarrhea-predominant IBS","volume":"73","author":"Zhang","year":"2020","journal-title":"Cell Signal"},{"issue":"7","key":"10.1016\/j.phrs.2022.106291_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2012.02.029","article-title":"Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis","volume":"10","author":"Lovell","year":"2012","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.phrs.2022.106291_bib34","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.cell.2015.02.047","article-title":"Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis","volume":"161","author":"Yano","year":"2015","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.phrs.2022.106291_bib35","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/nrgastro.2013.105","article-title":"Serotonin signalling in the gut--functions, dysfunctions and therapeutic targets","volume":"10","author":"Mawe","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.phrs.2022.106291_bib36","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/apt.13459","article-title":"Alterations in serotonin metabolism in the irritable bowel syndrome","volume":"43","author":"Thijssen","year":"2016","journal-title":"Aliment Pharm. Ther."},{"issue":"1","key":"10.1016\/j.phrs.2022.106291_bib37","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1053\/j.gastro.2006.11.020","article-title":"Alterations in expression of p11 and SERT in mucosal biopsy specimens of patients with irritable bowel syndrome","volume":"132","author":"Camilleri","year":"2007","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.phrs.2022.106291_bib38","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12876-017-0634-5","article-title":"Role of serotonin on the intestinal mucosal immune response to stress-induced diarrhea in weaning mice","volume":"17","author":"Dong","year":"2017","journal-title":"BMC Gastroenterol."},{"issue":"1","key":"10.1016\/j.phrs.2022.106291_bib39","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/gut.42.1.42","article-title":"Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study","volume":"42","author":"Bearcroft","year":"1998","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.phrs.2022.106291_bib40","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2011.01.052","article-title":"Impaired uptake of serotonin by platelets from patients with irritable bowel syndrome correlates with duodenal immune activation","volume":"140","author":"Foley","year":"2011","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.phrs.2022.106291_bib41","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/apt.15420","article-title":"Abnormalities of mucosal serotonin metabolism and 5-HT3 receptor subunit 3C polymorphism in irritable bowel syndrome with diarrhoea predict responsiveness to ondansetron","volume":"50","author":"Gunn","year":"2019","journal-title":"Aliment Pharm. Ther."},{"issue":"4","key":"10.1016\/j.phrs.2022.106291_bib42","doi-asserted-by":"crossref","first-page":"656","DOI":"10.5056\/jnm18037","article-title":"MicroRNA-200a Targets cannabinoid receptor 1 and serotonin transporter to increase visceral hyperalgesia in diarrhea-predominant irritable bowel syndrome rats","volume":"24","author":"Hou","year":"2018","journal-title":"J. Neurogastroenterol. Motil."},{"issue":"2","key":"10.1016\/j.phrs.2022.106291_bib43","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.bbrc.2015.11.102","article-title":"MicroRNA-24 inhibits serotonin reuptake transporter expression and aggravates irritable bowel syndrome","volume":"469","author":"Liao","year":"2016","journal-title":"Biochem Biophys. Res Commun."},{"key":"10.1016\/j.phrs.2022.106291_bib44","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.jad.2018.06.034","article-title":"CSF miR-16 expression and its association with miR-16 and serotonin transporter in the raphe of a rat model of depression","volume":"238","author":"Shao","year":"2018","journal-title":"J. Affect Disord."},{"issue":"37","key":"10.1016\/j.phrs.2022.106291_bib45","doi-asserted-by":"crossref","first-page":"13521","DOI":"10.3748\/wjg.v20.i37.13521","article-title":"Epidermal growth factor upregulates serotonin transporter and its association with visceral hypersensitivity in irritable bowel syndrome","volume":"20","author":"Cui","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.phrs.2022.106291_bib46","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1096\/fj.14-259598","article-title":"Gut microbes promote colonic serotonin production through an effect of short-chain fatty acids on enterochromaffin cells","volume":"29","author":"Reigstad","year":"2015","journal-title":"FASEB J."},{"issue":"4","key":"10.1016\/j.phrs.2022.106291_bib47","doi-asserted-by":"crossref","first-page":"G627","DOI":"10.1152\/ajpgi.00563.2010","article-title":"Epidermal growth factor upregulates serotonin transporter in human intestinal epithelial cells via transcriptional mechanisms","volume":"300","author":"Gill","year":"2011","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"3","key":"10.1016\/j.phrs.2022.106291_bib48","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1053\/j.gastro.2009.05.050","article-title":"Saccharomyces boulardii inhibits EGF receptor signaling and intestinal tumor growth in Apc(min) mice","volume":"137","author":"Chen","year":"2009","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.phrs.2022.106291_bib49","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1023\/A:1026689628136","article-title":"Effect of Saccharomyces boulardii on cAMP- and Ca2+ -dependent Cl- secretion in T84 cells","volume":"44","author":"Czerucka","year":"1999","journal-title":"Dig. Dis. Sci."},{"issue":"1","key":"10.1016\/j.phrs.2022.106291_bib50","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0016-5085(94)94403-2","article-title":"Saccharomyces boulardii inhibits secretagogue-mediated adenosine 3\u2032,5\u2032-cyclic monophosphate induction in intestinal cells","volume":"106","author":"Czerucka","year":"1994","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.phrs.2022.106291_bib51","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/0016-5085(93)90280-P","article-title":"Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum","volume":"104","author":"Pothoulakis","year":"1993","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.phrs.2022.106291_bib52","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.1128\/iai.64.12.5225-5232.1996","article-title":"Saccharomyces boulardii protease inhibits Clostridium difficile toxin A effects in the rat ileum","volume":"64","author":"Castagliuolo","year":"1996","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.phrs.2022.106291_bib53","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/19490976.2016.1267890","article-title":"Prospective randomized controlled study on the effects of Saccharomyces boulardii CNCM I-745 and amoxicillin-clavulanate or the combination on the gut microbiota of healthy volunteers","volume":"8","author":"Kabbani","year":"2017","journal-title":"Gut Microbes"},{"issue":"1","key":"10.1016\/j.phrs.2022.106291_bib54","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s40168-018-0538-9","article-title":"Enterobacteriaceae are essential for the modulation of colitis severity by fungi","volume":"6","author":"Sovran","year":"2018","journal-title":"Microbiome"},{"issue":"2","key":"10.1016\/j.phrs.2022.106291_bib55","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1080\/19490976.2015.1019693","article-title":"Characterization of the human gut microbiome during travelers' diarrhea","volume":"6","author":"Youmans","year":"2015","journal-title":"Gut Microbes"},{"issue":"1","key":"10.1016\/j.phrs.2022.106291_bib56","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/jgh.13471","article-title":"Alterations of gut microbiota in patients with irritable bowel syndrome: a systematic review and meta-analysis","volume":"32","author":"Zhuang","year":"2017","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.phrs.2022.106291_bib57","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jand.2019.05.015","article-title":"Gut microbial dysbiosis in the irritable bowel syndrome: a systematic review and meta-analysis of case-control studies","volume":"120","author":"Wang","year":"2020","journal-title":"J. Acad. Nutr. Diet."},{"issue":"1","key":"10.1016\/j.phrs.2022.106291_bib58","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1053\/j.gastro.2019.03.049","article-title":"Gut microbiota in patients with irritable bowel syndrome-a systematic review","volume":"157","author":"Pittayanon","year":"2019","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.phrs.2022.106291_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19113619","article-title":"Intestinal microbiome in irritable bowel syndrome before and after gut-directed hypnotherapy","volume":"19","author":"Peter","year":"2018","journal-title":"Int J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.phrs.2022.106291_bib60","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000012","article-title":"Alterations of gut microbiota in patients with irritable bowel syndrome based on 16S rRNA-targeted sequencing: a systematic review","volume":"10","author":"Duan","year":"2019","journal-title":"Clin. Transl. Gastroenterol."},{"issue":"2","key":"10.1016\/j.phrs.2022.106291_bib61","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/ajg.2014.427","article-title":"Intestinal microbiota and diet in IBS: causes, consequences, or epiphenomena","volume":"110","author":"Rajili\u0107-Stojanovi\u0107","year":"2015","journal-title":"Am. J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.phrs.2022.106291_bib62","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40168-019-0656-z","article-title":"Evidence for an association of gut microbial Clostridia with brain functional connectivity and gastrointestinal sensorimotor function in patients with irritable bowel syndrome, based on tripartite network analysis","volume":"7","author":"Labus","year":"2019","journal-title":"Microbiome"},{"issue":"5","key":"10.1016\/j.phrs.2022.106291_bib63","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1136\/gutjnl-2012-304042","article-title":"Characterisation of faecal protease activity in irritable bowel syndrome with diarrhoea: origin and effect of gut transit","volume":"63","author":"Tooth","year":"2014","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.phrs.2022.106291_bib64","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-2672.1988.tb02427.x","article-title":"Contribution of the microflora to proteolysis in the human large intestine","volume":"64","author":"Macfarlane","year":"1988","journal-title":"J. Appl. Bacteriol."},{"issue":"7","key":"10.1016\/j.phrs.2022.106291_bib65","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1136\/gutjnl-2011-301501","article-title":"An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota","volume":"61","author":"Jeffery","year":"2012","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.phrs.2022.106291_bib66","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s40168-018-0492-6","article-title":"Saturated long-chain fatty acid-producing bacteria contribute to enhanced colonic motility in rats","volume":"6","author":"Zhao","year":"2018","journal-title":"Microbiome"},{"issue":"5","key":"10.1016\/j.phrs.2022.106291_bib67","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1053\/j.gastro.2011.06.072","article-title":"Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome","volume":"141","author":"Saulnier","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.phrs.2022.106291_bib68","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.3389\/fmicb.2017.02307","article-title":"Wuji Wan formula ameliorates diarrhea and disordered colonic motility in post-inflammation irritable bowel syndrome rats by modulating the gut microbiota","volume":"8","author":"Chen","year":"2017","journal-title":"Front Microbiol"},{"issue":"12","key":"10.1016\/j.phrs.2022.106291_bib69","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1038\/s41564-019-0540-4","article-title":"Intestinal serotonin and fluoxetine exposure modulate bacterial colonization in the gut","volume":"4","author":"Fung","year":"2019","journal-title":"Nat. Microbiol"},{"issue":"1","key":"10.1016\/j.phrs.2022.106291_bib70","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/s12866-019-1610-8","article-title":"Saccharomyces boulardii alleviates ulcerative colitis carcinogenesis in mice by reducing TNF-\u03b1 and IL-6 levels and functions and by rebalancing intestinal microbiota","volume":"19","author":"Wang","year":"2019","journal-title":"BMC Microbiol"},{"issue":"7","key":"10.1016\/j.phrs.2022.106291_bib71","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1007\/s10096-020-03854-3","article-title":"Effect of Saccharomyces boulardii CNCM I-745 as complementary treatment of Helicobacter pylori infection on gut microbiome","volume":"39","author":"C\u00e1rdenas","year":"2020","journal-title":"Eur. J. Clin. Microbiol Infect. Dis."},{"issue":"16","key":"10.1016\/j.phrs.2022.106291_bib72","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1097\/CM9.0000000000000364","article-title":"Protective effect of Saccharomyces boulardii on intestinal mucosal barrier of dextran sodium sulfate-induced colitis in mice","volume":"132","author":"Dong","year":"2019","journal-title":"Chin. Med J."},{"issue":"1","key":"10.1016\/j.phrs.2022.106291_bib73","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1039\/D1FO02752B","article-title":"Saccharomyces boulardii alleviates DSS-induced intestinal barrier dysfunction and inflammation in humanized mice","volume":"13","author":"Li","year":"2022","journal-title":"Food Funct."},{"issue":"39","key":"10.1016\/j.phrs.2022.106291_bib74","doi-asserted-by":"crossref","first-page":"6165","DOI":"10.3748\/wjg.v11.i39.6165","article-title":"Effects of Saccharomyces boulardii on fecal short-chain fatty acids and microflora in patients on long-term total enteral nutrition","volume":"11","author":"Schneider","year":"2005","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.phrs.2022.106291_bib75","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jnutbio.2018.08.005","article-title":"Intestinal anti-inflammatory effect of the probiotic Saccharomyces boulardii in DSS-induced colitis in mice: Impact on microRNAs expression and gut microbiota composition","volume":"61","author":"Rodr\u00edguez-Nogales","year":"2018","journal-title":"J. Nutr. Biochem"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661822002365?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661822002365?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:34:10Z","timestamp":1760913250000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661822002365"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":75,"alternative-id":["S1043661822002365"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2022.106291","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Saccharomyces boulardii, a yeast probiotic, inhibits gut motility through upregulating intestinal serotonin transporter and modulating gut microbiota","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2022.106291","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106291"}}